These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 30105825)
1. Risk of developing radiogenic cancer following photon-beam radiotherapy for Graves' orbitopathy. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Med Phys; 2018 Oct; 45(10):4775-4782. PubMed ID: 30105825 [TBL] [Abstract][Full Text] [Related]
2. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581 [TBL] [Abstract][Full Text] [Related]
3. Organ-specific radiation-induced cancer risk estimates due to radiotherapy for benign pigmented villonodular synovitis. Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J Phys Med Biol; 2016 Sep; 61(17):6400-12. PubMed ID: 27499236 [TBL] [Abstract][Full Text] [Related]
4. Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis? Mazonakis M; Lyraraki E; Tzedakis A; Damilakis J Phys Med; 2017 Nov; 43():73-78. PubMed ID: 29195566 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model. Mazonakis M; Varveris C; Lyraraki E; Damilakis J Med Phys; 2015 Nov; 42(11):6309-16. PubMed ID: 26520723 [TBL] [Abstract][Full Text] [Related]
6. Second cancer risk assessments after involved-site radiotherapy for mediastinal Hodgkin lymphoma. Mazonakis M; Lyraraki E; Damilakis J Med Phys; 2017 Jul; 44(7):3866-3874. PubMed ID: 28493609 [TBL] [Abstract][Full Text] [Related]
7. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma. Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368 [TBL] [Abstract][Full Text] [Related]
8. The risk of radiation-induced carcinogenesis after external beam radiotherapy of Graves' orbitopathy. Akmansu M; Dirican B; Bora H; Gurel O Ophthalmic Res; 2003; 35(3):150-3. PubMed ID: 12711842 [TBL] [Abstract][Full Text] [Related]
9. Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty. Mazonakis M; Berris T; Lyraraki E; Damilakis J Med Phys; 2013 Oct; 40(10):101702. PubMed ID: 24089892 [TBL] [Abstract][Full Text] [Related]
10. Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin's disease. Kourinou KM; Mazonakis M; Lyraraki E; Papadaki HΑ; Damilakis J Phys Med; 2019 Jan; 57():100-106. PubMed ID: 30738513 [TBL] [Abstract][Full Text] [Related]
11. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT. Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226 [TBL] [Abstract][Full Text] [Related]
12. Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma. Mazonakis M; Stratakis J; Lyraraki E; Damilakis J Phys Med; 2019 Apr; 60():44-49. PubMed ID: 31000085 [TBL] [Abstract][Full Text] [Related]
13. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source. Suleiman SA; Qi Y; Chen Z; Xu XG Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393 [TBL] [Abstract][Full Text] [Related]
14. Secondary bladder and rectal cancer risk estimates following standard fractionated and moderately hypofractionated VMAT for prostate carcinoma. Mazonakis M; Kachris S; Damilakis J Med Phys; 2020 Jul; 47(7):2805-2813. PubMed ID: 32266979 [TBL] [Abstract][Full Text] [Related]
15. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT. Suleiman SA; Qi Y; Pi Y; George Xu X Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393 [TBL] [Abstract][Full Text] [Related]
16. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study. Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104 [TBL] [Abstract][Full Text] [Related]
17. Development of clinical application program for radiotherapy induced cancer risk calculation using Monte Carlo engine in volumetric-modulated arc therapy. Kang DJ; Shin YJ; Jeong S; Jung JY; Lee H; Lee B Radiat Oncol; 2021 Jun; 16(1):108. PubMed ID: 34118968 [TBL] [Abstract][Full Text] [Related]
18. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer. Donovan EM; James H; Bonora M; Yarnold JR; Evans PM Med Phys; 2012 Oct; 39(10):5814-24. PubMed ID: 23039620 [TBL] [Abstract][Full Text] [Related]
19. SECOND CANCER RISK FROM RADIATION THERAPY FOR COMMON SOLID TUMORS DIAGNOSED IN REPRODUCTIVE-AGED FEMALES. Mazonakis M; Kachris S; Damilakis J Radiat Prot Dosimetry; 2018 Dec; 182(2):208-214. PubMed ID: 29608744 [TBL] [Abstract][Full Text] [Related]
20. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy. Yoon M; Shin DH; Kim J; Kim JW; Kim DW; Park SY; Lee SB; Kim JY; Park HJ; Park BK; Shin SH Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):637-46. PubMed ID: 20932690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]